BDBM202846 US10245267, Example 199::US10709712, Example 199::US9242969, 199::US9694016, 199

SMILES Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1csc(n1)N1CCOCC1

InChI Key InChIKey=BNEUFTPBYFEBMT-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 202846   

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.29nMpH: 7.5 T: 2°CAssay Description:Final assay conditions were 4 pM cRaf, 3 uM ATP, 10 nM biotin tagged MEK1 kinase dead protein substrate. Reactions were performed in Greiner384 well ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Novartis

US Patent
LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 3.60nMpH: 7.5 T: 2°CAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2x final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.30nMpH: 7.5 T: 2°CAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2x final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.29nMpH: 7.5 T: 2°CAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2x final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Novartis

US Patent
LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 3.60nMAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.30nMAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.29nMAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.29nMAssay Description:C-Raf TR refers to a truncated C-Raf protein, a Δ1-324 deletion mutant.C-Raf FL refers to the full-length C-Raf protein.Full length MEK1 with an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Novartis

US Patent
LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 3.60nMAssay Description:C-Raf TR refers to a truncated C-Raf protein, a Δ1-324 deletion mutant.C-Raf FL refers to the full-length C-Raf protein.Full length MEK1 with an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM202846(US9694016, 199 | US9242969, 199 | US10245267, Exam...)
Affinity DataIC50: 1.30nMAssay Description:C-Raf TR refers to a truncated C-Raf protein, a Δ1-324 deletion mutant.C-Raf FL refers to the full-length C-Raf protein.Full length MEK1 with an...More data for this Ligand-Target Pair
In DepthDetails
US Patent